An interdisciplinary team at University Health Network (UHN) received the Mission of Excellence Team Inventor of the Year Award for creating H.A.L.O., a remote patient monitoring system. Launched as a company in early 2025, H.A.L.O. now operates across 50 inpatient units, providing continuous observation of high‑risk patients and generating significant efficiency and cost benefits. The award recognizes the collaboration between clinical inventors, engineering, and Altum Health partners that turned a bedside prototype into a commercial virtual‑care service. The system’s success underscores the growing demand for scalable digital health solutions.
The Schroeder Ambulatory Centre (SAC), a $300 million private non‑profit facility in Richmond Hill, Ontario, has opened its doors with operating rooms, MRI, CT and GI endoscopy capabilities while awaiting full accreditation. It secured $14 million from the provincial government to deliver...

Caterpillar’s Electrification + Energy Solutions Division has created a Product Support Field Engineering team to back its first‑generation battery‑electric mining equipment. The team troubleshoots hardware in real‑world sites, trains dealers on high‑voltage safety, and channels field observations back to engineers....

A congressional hearing highlighted that current Medicare GME funding formulas leave rural hospitals like Phelps Health struggling to bridge the $5‑$7 million gap between planning grants and accreditation costs. Hospital leaders argue that outdated per‑resident caps and rigid grant structures create...

A U.S. Air Force C‑146A Wolfhound collided with a concrete barrier while attempting a road take‑off during a joint training exercise in Laoac, Pangasinan, injuring all five crew members. The drill, conducted with the Armed Forces of the Philippines, was...
Trillium Health Partners has launched a clinical AI application that automatically detects intracranial hemorrhage on head CT scans, flagging urgent cases in real time. The tool, sourced through Sectra Amplifier Services, also identifies midline shift, mass effect and skull fractures,...

Rental vacancy data has been the quietly positive story for #mortgagerares for over a year now. @housingwire @sarahteresa6 #realestate #housing #economics #chartdaddy
South‑California entertainment firm Transparent Arts has signed a strategic partnership with Jay Park’s More Vision label to drive international expansion. The deal brings More Vision’s roster—including K‑pop star Chung Ha and breakout boy band LNGSHOT—under Transparent Arts’ global business platform, which...
The Institute of Practitioners in Advertising (IPA) has released the iList 2026 shortlist, highlighting agencies that have demonstrated outstanding diversity, equity and inclusion (DEI) initiatives. The shortlist features a select group of agencies that will be interviewed by a panel...

Ukraine’s leading drone maker Ukrspecsystems opened a £200 million production and testing facility in Suffolk, creating up to 500 British jobs. The plant will manufacture SHARK, Mini‑SHARK and PD‑2 drones that have already inflicted nearly $3 billion of damage on Russian forces....

Professor Mimi Zou warns that the United Kingdom’s rapid lawtech expansion could stall if women remain under‑represented. The sector has grown more than 90% since 2020, driven by AI tools like ChatGPT and large‑language‑model platforms such as Harvey. Yet only...

Researchers have engineered ligand‑conjugated mRNA‑lipid nanoparticles that home specifically to the endometrium, delivering therapeutic mRNA directly to uterine tissue. In a murine model of endometrial injury, the targeted formulation restored embryo implantation rates to near‑normal levels. Safety profiling showed reduced...
Vistance Networks completed the CCS divestiture to Amphenol, using the proceeds to retire all debt, redeem preferred equity and declare a $10‑per‑share special cash distribution. The company posted a 40% jump in full‑year net sales to $1.93 billion, with Q4 core...
MidCap Financial Investment Corp reported Q4 2025 GAAP net income of $54.3 million ($0.42 per share) and distributable earnings of $27.8 million ($0.27 per share). The REIT acquired $1.9 billion of loans and securities, expanding its Agency MBS portfolio by over 50% and...
Castle Biosciences reported $344.2 million revenue for 2025, beating its own guidance, and projected $340‑$350 million for 2026. Core test volumes surged, with TissueCypher reports up 86% to 39,014 and total reports reaching 105,053, while DecisionDx‑Melanoma grew modestly 9%. The company posted...
Compania de Minas Buenaventura reported Q2 2025 EBITDA of $130 million and net income of $91 million, driven by a 28% rise in copper output while silver and gold fell 11% and 17% respectively. The San Gabriel project reached 88% completion with $82 million CapEx...
Kimbell Royalty Partners reported Q4 2025 production of 25,627 BOE per day and adjusted EBITDA of $64.8 million, while proved reserves rose 8% to a record 73 million BOE. The company declared a $0.37 per unit distribution, a 6% increase, classified entirely as return of...
Align Technology reported a record $1.05 billion Q4 2025 revenue, up 5.3% year‑over‑year, driven by strong clear‑aligner sales and expanding Systems & Services. Non‑GAAP operating margin improved to 26.1%, the highest since 2021, while cash balances rose to $1.09 billion. The company...
Daqo New Energy reported a 39.7% drop in annual polysilicon production to 123,652 metric tons, staying within its guided range, while sales outpaced output at 126,707 tons. Revenue fell 35% to $665 million and average selling price slipped 7.2%, yet the...
Ducommun reported a record $212.6 million Q3 revenue, up 6% year‑over‑year, and achieved a new high gross margin of 26.6%. The defense segment drove growth, expanding 13% with missiles up 21%, while commercial aerospace fell 10% amid Boeing and Spirit destocking....
National MI (NMI Holdings) reported a record 2025 year, posting $388.9 million net income (up 8%), diluted EPS of $4.92 (up 11%) and a 16.2% return on equity. Insurance in force reached $221.4 billion, a 5.4% year‑over‑year increase, while fourth‑quarter new insurance...
Pacira BioSciences reported a record $726 million in total 2025 revenue and an all‑time high non‑GAAP gross margin of 80%, driven by growth in its flagship product EXPAREL. EXPAREL sales rose 7% year‑over‑year to $155.8 million, though the increase was partially offset...
Broadcasters are buoyed by FCC Chair Brendan Carr’s hints of relaxed ownership rules and a Trump endorsement of Nexstar’s $6 billion Tegna acquisition. Nexstar, Scripps and Sinclair all highlighted this regulatory optimism in recent earnings calls, stressing strategic M&A and operational...
Main Street Capital reported a GAAP net loss of $14.4 million for Q4 2025, but generated adjusted distributable earnings of $0.15 per share, bringing full‑year adjusted earnings to $0.64 per share. The loan portfolio expanded 13% to $2.7 billion, driven by 32...
MBIA Inc. reported a markedly narrower Q4 2018 GAAP loss of $7 million, driven by reduced loss‑adjustment expenses on its Puerto Rico exposure and lower LAE across structured‑finance assets. The company completed a restructuring of COFINA bonds, cutting insured debt service exposure...
Marcus Corp reported a 9.7% drop in consolidated revenue to $210 million for fiscal Q3 2025, driven primarily by a 16% decline in theater revenue and an 18.7% fall in attendance that left box‑office performance 3.8 percentage points below the national average....
TriMas Corp reported third‑quarter 2025 net sales of $269 million, a 17% year‑over‑year increase driven by 16% organic growth and strong aerospace performance. Operating profit rose 34% to $30.3 million and adjusted EBITDA climbed 25% to $48 million, while adjusted EPS jumped 42%...
PolyPid announced successful completion of the Phase III SHIELD II trial, with D‑PLEX100 achieving its primary and key secondary endpoints and demonstrating a meaningful reduction in surgical site infections. The FDA provided written support for a rolling NDA review, and the company...
Definium Therapeutics reported that its lead psychedelic candidate DT120 ODT has fully enrolled the EMERGE Phase III trial for major depressive disorder, with top‑line results expected in late Q2 2026. The VOYAGE Phase III study for generalized anxiety disorder is...
Intellia Therapeutics announced that the FDA has placed a clinical hold on its nex‑z MAGNITUDE and MAGNITUDE‑2 Phase III trials after a patient death and liver enzyme abnormalities. The company is implementing intensified safety monitoring and data reviews while awaiting regulatory...
Morgan Stanley delivered record 2025 results, posting $70.6 billion in total revenue and a historic $10.21 earnings per share. Total client assets rose to $9.3 trillion, while wealth management generated $31.8 billion in revenue and attracted $356 billion of net new assets. The firm’s...
OPKO Health reported a $369 million cash position for Q4 2025, driven by asset sales, BARDA funding and partnership payments. The company repurchased 34.6 million shares for $47 million and allocated $109 million to stock and convertible note buybacks. Diagnostics revenue dropped to $71.1 million, but...
News Corp reported Q4 2025 revenue of $2.4 billion, a 6% year‑over‑year increase, and total segment EBITDA of $521 million, up 9% despite a $16 million one‑time charge at HarperCollins. Adjusted earnings per share rose to $0.40 and profitability margin improved to 22.1%,...
NexPoint Residential Trust reported a Q4 2025 net loss of $10.3 million ($0.41 per share), an improvement from the $26.9 million loss a year earlier, while total revenue slipped to $62.1 million and NOI fell 4.7% to $37.1 million. The REIT repurchased 223,000 shares...
Eagle Point Income Company reported Q3 2025 results, with NAV increasing to $14.21 per share and recurring cash flows covering distributions. Net investment income after losses was $0.26 per share, while the board reduced the monthly distribution to $0.11 amid...
PureCycle Technologies reported Q4 2025 revenue of $2.7 million, marking a fourth consecutive quarter of sequential growth, while achieving record production at its Denver (14 million lb processed) and Ironton (7.5 million lb produced) facilities. The company reduced feedstock procurement costs by $0.06 per pound,...
Teleflex reported 2025 adjusted EPS of $6.98, an 8.7% increase, while outlining a $2.03 billion divestiture plan that will net roughly $1.8 billion after tax. Management pledged to allocate $1 billion to share repurchases and use the remaining $800 million to reduce debt, bolstering...

Researchers injected acetate, a common metabolic by‑product, into mice and tested long‑term memory using spatial and object‑recognition tasks. Female mice that received acetate showed significantly better performance 24 hours later, while male mice displayed little to no improvement. The memory...
iQIYI reported total revenue of RMB 6.7 billion for Q4 2025, a modest 1% sequential increase driven primarily by premium long‑form dramas and a 48% jump in distribution revenue from theatrical investments. Membership services rose 3% sequentially, while online advertising slipped 2% as...
Akebia Therapeutics reported 2025 total revenue of $236.2 million, a 47% increase driven by the commercial launch of Vafseo and higher Auryxia sales. Net product revenue reached $227 million, with Vafseo contributing $45.8 million and gaining prescribing access for 290,000 dialysis patients. The...
Hilton Grand Vacations reported fourth‑quarter 2020 revenue of $233 million, a 5% sequential increase, and adjusted EBITDA of $35 million (excluding a $3 million CARES Act credit). The company posted a net loss of $143 million, driven by a $209 million non‑cash land impairment. Contract...
Hertz Global Holdings reported $2.5 billion in Q4 2025 revenue and a $190 million adjusted corporate EBITDA, marking a $350 million year‑over‑year improvement and the first positive EPS in two years. Fleet utilization reached 84%, the highest since 2018, despite a 2% recall rate...
Royal Gold reported record 2025 results, with annual revenue of $1 billion, a 43% increase, and operating cash flow of $705 million, up 33%. Net income rose 40% to $466 million, while adjusted net income hit $510 million, boosted by strong gold prices and...
CubeSmart reported fourth‑quarter 2025 FFO of $0.65 per share, with same‑store revenue slipping 1% and occupancy easing to 89.9%. Move‑in rates rose 2.5% year‑over‑year, marking the first positive growth since Q1 2022, while churn held steady at 4‑5% monthly. The REIT...
Ascendis (SNDX) reported €720 million total 2025 revenue, driven by €477 million from Yorvipath and €206 million from Skytrofa. Q4 operating profit hit €10 million and cash flow reached €73 million, leaving €616 million in cash at year‑end. Management guided 2026 operating cash flow of roughly...

Turkey’s state‑owned TPAO and Britain’s BP have signed a comprehensive oil and gas cooperation agreement targeting Iraq’s Kirkuk basin. TPAO aims to lift 500,000 barrels per day by 2028, while BP’s initial target is 328,000 barrels per day, with plans...
Krispy Kreme reported fourth‑quarter 2024 revenue of $404 million, reflecting 21% year‑over‑year growth despite a cyber‑security breach that trimmed $11 million of sales and $10 million of adjusted EBITDA. The company added more than 2,800 new delivered‑fresh‑daily (DFD) doors, driving a 34% increase...
Delcath Systems reported record 2025 revenue of $85.2 million, driven by over 40% volume growth and 28 REMS‑certified treatment centers. Gross margins held at 85% for Q4 and 86% for the full year, while adjusted EBITDA turned positive to $25.1 million and...
Charter Communications reported its first quarterly video subscriber increase since 2020, adding roughly 44,000 net video customers in Q4 2025. The gain sparked optimism on earnings calls at Nexstar, Sinclair and AMC Networks, which highlighted the role of bundled over‑the‑top...
Rhythm Pharmaceuticals reported a strong Q4 2025, with product revenue rising to $57.3 million—a 12% sequential increase and 37% year‑over‑year growth. Full‑year revenue jumped 50% to $194.8 million, driven by expanding U.S. sales and broader international access for IMCIVREE. The company highlighted...